テストステロン置換療法の世界市場2016-2020

◆英語タイトル:Global Testosterone Replacement Therapy Market 2016-2020
◆商品コード:IRTNTR9274
◆発行会社(調査会社):Technavio
◆発行日:2016年7月27日
◆ページ数:59
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆産業分野:医療
◆販売価格オプション(消費税別)
Single User(1名利用)USD2,500 ⇒換算¥285,000見積依頼/購入/質問フォーム
Five User(~5名利用)USD3,000 ⇒換算¥342,000見積依頼/購入/質問フォーム
Enterprise License(全社内共有可)USD4,000 ⇒換算¥456,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご確認ください。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(支払期限と方法は調整可能、振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はTechnavio社の日本における正規販売代理店です。Technavio社の概要及び新刊レポートはこちらでご確認いただけます。
当調査レポートでは、テストステロン置換療法の世界市場について調査・分析し、エグゼクティブサマリー、市場概観、市場概観、業界の構造分析、テストステロン置換療法の世界市場規模及び予測、剤形別分析、地域別分析/市場規模、購買基準、市場の成長要因、市場の課題、製品パイプライン分析、市場動向、競争状況などの情報をお届けいたします。
【レポートの概要】

About Testosterone Replacement Therapy
Testosterone replacement therapy, also called androgen replacement therapy, is typically used to treat hypogonadism. Testosterone, a hormone produced by the testes, is responsible for the development of secondary sexual characters in men. The levels of testosterone decrease gradually with age, but sometimes this decline is seen even in young men, leading to a condition known as hypogonadism. This can be treated with external supply of testosterone in the form of gels, patches, injectable, or oral drugs.

Technavio’s analysts forecast the global testosterone replacement therapy market is gradually declining and will post a CAGR of (3.35) % during the period 2016-2020.

[Covered in this report]
The report covers the present scenario and the growth prospects of the global testosterone replacement therapy market for 2016-2020. To calculate the market size, the report considers the revenue generated from the sales of branded and generic drugs that treat and prevent hypogonadism.

The market is divided into the following segments based on geography:
• Americas
• APAC
• EMEA

Technavio’s report, Global Testosterone Replacement Therapy Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

[Key vendors]
• AbbVie
• Allergan
• Eli Lilly and Company
• Endo Pharmaceuticals

[Other prominent vendors]
• Acerus Pharmaceuticals Corporation
• Antares Pharma
• Bayer HealthCare Pharmaceuticals
• Bedford Labs
• Clarus Therapeutics
• Ferring Pharmaceuticals
• Forendo Pharma
• Juniper Pharmaceuticals
• Lipocine
• MetP Pharma
• Mylan
• Pfizer
• ProStrakan Group
• Repros Therapeutics
• Sandoz
• TesoRx
• Teva Pharmaceuticals

[Market driver]
• Increase in older population
• For a full, detailed list, view our report

[Market challenge]
• FDA warnings on use of testosterone products
• For a full, detailed list, view our report

[Market trend]
• Entry of SARMs
• For a full, detailed list, view our report

[Key questions answered in this report]
• What will the market size be in 2020 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?

※You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.

【レポートの目次】

PART 01: Executive summary
• Highlights

PART 02: Scope of the report
• Market overview
• Top-vendor offerings

PART 03: Market research methodology
• Research methodology
• Economic indicators

PART 04: Introduction
• Key market highlights

PART 05: Hypogonadism
• Understanding Hypergonadism
• Pathophysiology
• Symptoms
• Diagnosis
• Treatment

PART 06: Pipeline analysis
• TESTAVAN
• Vibex QST
• LPCN 1021
• REXTORO
• Enclomiphene
• LPCN 1111
• TSX-002
• TEFINA
• THG-1001
• MetP Testosterone Nasal Gel

PART 07: Key buying criteria

PART 08: Market landscape
• Global endocrinology drugs market
• Global testosterone replacement therapy market
• Five forces analysis

PART 09: Market segmentation by dosage form
• Gels
• Injectables
• Patches
• Others

PART 10: Geographical segmentation
• Global testosterone replacement therapy market by geography 2015-2020
• Testosterone replacement therapy market in Americas
• Testosterone replacement therapy market in EMEA
• Testosterone replacement therapy market in APAC

PART 11: Market drivers
• Increase in older population
• High incidence of testosterone deficiency
• Rise in chronic diseases
• Increase in awareness

PART 12: Impact of drivers

PART 13: Market challenges
• Generic erosion
• FDA warnings on use of testosterone products
• Adverse effects
• Physicians are reluctant to prescribe medications with testosterone
• Reluctance to discuss condition

PART 14: Impact of drivers and challenges

PART 15: Market trends
• Entry of SARMs
• Support of patient assistance programs
• Focus on emerging markets
• Application in new therapeutic indications

PART 16: Vendor landscape
• Competitive scenario
• Market analysis 2015
• AbbVie
• Allergan
• Eli Lilly
• Endo International
• Other prominent vendors

PART 17: Appendix
• List of abbreviations

PART 18: Explore Technavio

[List of Exhibits]

Exhibit 01: Product offerings
Exhibit 02: Normal levels of testosterone based on gender
Exhibit 03: Normal levels of testosterone at different ages
Exhibit 04: Timeline of testosterone replacement therapy products
Exhibit 05: Advantages and risks associated with use of testosterone products
Exhibit 06: Causes of hypogonadism
Exhibit 07: Symptoms of hypogonadism
Exhibit 08: Diagnostic algorithm of hypogonadism
Exhibit 09: Pipeline portfolio: Global testosterone drugs market
Exhibit 10: Key buying criteria for testosterone replacement therapy
Exhibit 11: Global endocrinology drugs market 2015-2020 ($ billions)
Exhibit 12: Market share of global testosterone replacement therapy market in global endocrinology drugs market
Exhibit 13: Global testosterone replacement therapy market 2015-2020 ($ billions)
Exhibit 14: Five forces analysis
Exhibit 15: Global testosterone replacement therapy market by dosage form 2015
Exhibit 16: Segmentation of global testosterone replacement therapy market based on geography 2015
Exhibit 17: Global testosterone replacement therapy market by geography 2015-2020 ($ billions)
Exhibit 18: Global testosterone replacement therapy market by geography 2015-2020
Exhibit 19: Testosterone replacement therapy market in Americas 2015-2020 ($ billions)
Exhibit 20: Percentage share of US in testosterone replacement therapy market 2015
Exhibit 21: Testosterone replacement therapy market in EMEA 2015-2020 ($ billions)
Exhibit 22: Testosterone replacement therapy market in EMEA 2015-2020 ($ billions)
Exhibit 23: Global testosterone replacement therapy market: YoY growth and revenue based on geography 2015-2020
Exhibit 24: Impact of drivers
Exhibit 25: Impact of drivers and challenges
Exhibit 26: AbbVie: YoY revenue and growth rate of AndroGel 2013-2015 ($ billions)
Exhibit 27: AbbVie: Key takeaways
Exhibit 28: Allergan: Key takeaways
Exhibit 29: Eli Lilly: YoY revenue and growth rate of Axiron 2013-2015 ($ millions)
Exhibit 30: Geographical segmentation of Axiron by revenue 2015
Exhibit 31: Eli Lilly: Key takeaways
Exhibit 32: Endo International: YoY revenue and growth rate of Fortesta 2013-2015 ($ millions)
Exhibit 33: Endo: Key takeaways



【掲載企業】

AbbVie, Allergan, Eli Lilly, Endo International, Acerus Pharmaceuticals, Antares Pharma, Bayer HealthCare Pharmaceuticals, Bedford Labs, Clarus Therapeutics, Ferring Pharmaceuticals, Forendo Pharma, Juniper Pharmaceuticals, Lipocine, MetP Pharma, Mylan, Pfizer, ProStrakan, Repros Therapeutics, Sandoz, TesoRx, Teva Pharmaceuticals.

【レポートのキーワード】

テストステロン置換療法、アンドロゲン置換療法、性腺機能低下症

【調査方法】

一次資料による調査(業界専門家、ベンダー、代理店、顧客等を対象にしたデプスインタビュー調査など)及び二次資料による調査(Technavio独自のプラットフォーム、産業書籍、企業報告書、ニュース記事、アナリストレポート、貿易協会、政府機関発行データなど)

★調査レポート[テストステロン置換療法の世界市場2016-2020]販売に関する免責事項
★調査レポート[テストステロン置換療法の世界市場2016-2020]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆